Miriam Monge Joins Sartorius Stedim Biotech - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Miriam Monge Joins Sartorius Stedim Biotech


Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, introduced on Aug. 26 Miriam Monge as director of marketing for SSB’s integrated solutions unit. Monge will focus on sharpening SSB’s profile as an integrated solution provider for the biopharmaceutical industry.

Monge has more than 20 years of experience in the biopharmaceutical manufacturing sector and served as vice president of sales and marketing at Biopharm Services. She is a committee member of the International Society for Pharmaceutical Engineering and one of the founders of the Global Disposable Community of Practice. She regularly authors articles for technical bioprocess journals, analyzing the impact of disposable technologies on biomanufacturing.

Source: Sartorius Stedim Biotech

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here